- Global sustainability rulemaking is recalibrating, signaling a reset, not a retreat
- Crosscurrents in the US: Many states’
Recent ESG legal developments
The November issue of our monthly newsletter Horizon is now available. Learn more about an array of developments in sustainability law – among them, key decisions emerging from the 2025 United Nations Climate Change Conference (COP30), the Ninth Circuit’s stay on enforcement of California SB 261, the deadlock over reforms
Continue Reading Recent ESG legal developments
SEC Division of Corporation Finance announces significant change to shareholder proposal no-action process for upcoming proxy season
On November 17, 2025, the United States Securities and Exchange Commission (SEC)’s Division of Corporation Finance announced that it would significantly curtail its review of no-action submission requests for the upcoming proxy season (October 1, 2025 –September 30, 2026).
According to its statement, the SEC staff will not respond
Continue Reading SEC Division of Corporation Finance announces significant change to shareholder proposal no-action process for upcoming proxy season
SEC publishes filing guidance following end of government shutdown
After the government reopened on November 13, 2025, the United States Securities and Exchange Commission (SEC) issued a statement including questions and answers (Q&A) related to filings made during or after the federal government shutdown. The SEC noted that more than 900 registration statements were filed during the shutdown.
In
Continue Reading SEC publishes filing guidance following end of government shutdown
2026 SEC filing deadlines and financial statement staleness dates calendar
We are pleased to announce the availability of our calendar showing Securities and Exchange Commission (SEC) filing deadlines and financial statement staleness dates for 2026.
Public companies are encouraged to keep in mind these important deadlines and dates for meeting their SEC reporting obligations for the forthcoming year.
About DLA
Continue Reading 2026 SEC filing deadlines and financial statement staleness dates calendar
Equity lines of credit and at-the-market offerings: Alternative public financing options
For public companies looking to raise capital relatively quickly and at a lower cost, equity lines of credit (ELOCs) and at-the-market equity offerings (ATMs) may be viable options. Both allow companies to control the timing and volume of sales of equity securities and offer processes that are generally less disruptive
Continue Reading Equity lines of credit and at-the-market offerings: Alternative public financing options
Recent ESG legal developments
The October issue of Horizon covers late-breaking developments in sustainability law, among them CARB’s postponement of rulemaking – but not reporting deadlines – for SBs 253 and 261; the historic TotalEnergies greenwashing decision; proposed changes to the EUDR that would preserve current reporting dates; federal banking regulators’ withdrawal of climate
Continue Reading Recent ESG legal developments
SEC signals potentially significant changes to Rule 14a-8 shareholder proposal process
On October 9, 2025, during a keynote address at the John L. Weinberg Center for Corporate Governance’s 25th Anniversary Gala, United States Securities and Exchange Commission (SEC) Chairman Paul Atkins suggested that the SEC may be amenable to arguments from Delaware-incorporated companies seeking to exclude precatory shareholder proposals from
Continue Reading SEC signals potentially significant changes to Rule 14a-8 shareholder proposal process
DLA Piper hosts bootcamp for biotech and medtech companies
On October 20, 2025, DLA Piper held a bootcamp for pre-IPO and growth-stage companies in the biotech and medtech industries in the firm’s New York office. Attended by nearly 100 individuals, the bootcamp covered topics including late-stage financings, paths for going public, financial preparedness, regulatory considerations, compliance issues, intellectual property
Continue Reading DLA Piper hosts bootcamp for biotech and medtech companies
Key capital market trends: Digital asset treasuries
US public companies increasingly embrace digital assets as part of their corporate treasury strategies. Known as digital asset treasury (DAT) companies, these public companies, at the core of their revamped business model, pursue long-term accumulation of significant reserves of digital assets while employing sophisticated, yield-enhancing trading strategies.
DATs have raised
Continue Reading Key capital market trends: Digital asset treasuries